These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3429383)

  • 41. Odontogenic infections: Part two. Microbiology, antibiotics and management.
    Sands T; Pynn BR; Katsikeris N
    Oral Health; 1995 Jun; 85(6):11-4, 17-21, 23 passim. PubMed ID: 8779762
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Activity of roxithromycin against Toxoplasma gondii in murine models.
    Chang HR; Pechère JC
    J Antimicrob Chemother; 1987 Nov; 20 Suppl B():69-74. PubMed ID: 3429388
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment of orofacial infections of odontogenic origin.
    Heimdahl A; Nord CE
    Scand J Infect Dis Suppl; 1985; 46():101-5. PubMed ID: 3865348
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Midecamycin activity against aerobic and anaerobic bacteria].
    Dubini F; Balsari A
    G Ital Chemioter; 1985; 32(3):539-44. PubMed ID: 3836904
    [No Abstract]   [Full Text] [Related]  

  • 45. The role of adjunctive Rodogyl therapy in the treatment of advanced periodontal disease. A longitudinal clinical and microbiologic study.
    Quee TC; Chan EC; Clark C; Lautar-Lemay C; Bergeron MJ; Bourgouin J; Stamm J
    J Periodontol; 1987 Sep; 58(9):594-601. PubMed ID: 3309251
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Bacterial spectra and antibiotics in odontogenic infections. Renaissance of the penicillins?].
    Eckert AW; Maurer P; Wilhelms D; Schubert J
    Mund Kiefer Gesichtschir; 2005 Nov; 9(6):377-83. PubMed ID: 16261393
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacokinetics of a new macrolide, roxithromycin, in infants and children.
    Demotes-Mainard FM; Vinçon GA; Albin HC
    J Clin Pharmacol; 1989 Aug; 29(8):752-6. PubMed ID: 2778098
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Activity of nadifloxacin (OPC-7251) and seven other antimicrobial agents against aerobic and anaerobic Gram-positive bacteria isolated from bacterial skin infections.
    Nenoff P; Haustein UF; Hittel N
    Chemotherapy; 2004 Oct; 50(4):196-201. PubMed ID: 15452398
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Comparative clinical study of roxithromycin and josamycin for suppurative skin and soft tissue infections by a double-blind method].
    Nohara N; Akagi O; Kanzaki H; Kanamoto A; Ohara A; Ohkawara A; Fukaya T; Kobayashi H; Yasuda H; Tagami H
    Kansenshogaku Zasshi; 1989 Mar; 63(3):203-27. PubMed ID: 2504834
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The evaluation of the clinical efficacy and tolerance of azithromycin in odontostomatological infections].
    Varvara G; D'Arcangelo C
    Minerva Stomatol; 1998; 47(1-2):57-62. PubMed ID: 9578649
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Clinical studies on TMS-19-Q.O tablets, the preparation of a new macrolide antibiotic, in the field of oral surgery].
    Sasaki J; Yamada Y; Takai H; Ohmura H; Abe H; Shiki K; Narita Y; Michi K; Ohno K; Kawanishi I
    Jpn J Antibiot; 1985 Mar; 38(3):615-33. PubMed ID: 3897602
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The in-vitro activity of roxithromycin, a new macrolide antibiotic, in comparison with that of erythromycin.
    King A; Phillips I
    Drugs Exp Clin Res; 1987; 13(9):563-6. PubMed ID: 3428135
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Are antibiotics beneficial for the treatment of symptomatic dental infections?
    Tichter AM; Perry KJ
    Ann Emerg Med; 2015 Mar; 65(3):332-3. PubMed ID: 25477181
    [No Abstract]   [Full Text] [Related]  

  • 54. Antibacterial effect of imipenem in vitro against important aerobic and anaerobic strains isolated from clinical specimens.
    Klietmann W; Focht J; Nösner K
    Chemioterapia; 1987 Aug; 6(4):243-50. PubMed ID: 3477332
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Spectrum of pathogens in odontogenous abscesses in the patients of the Tübingen Department of Maxillofacial Surgery].
    Schmelzle R; Schwenzer N; Ullmann U; Germey M
    Dtsch Zahnarztl Z; 1978 Nov; 33(11):763-5. PubMed ID: 282982
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [In vitro activity of roxithromycin against hospital bacteria and the concordance curve].
    Soussy CJ; Chanal M; Kitzis MD; Duval J; Cluzel R; Acar JF
    Pathol Biol (Paris); 1988 May; 36(5):420-4. PubMed ID: 2900488
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serial doxycycline and metronidazole in prevention of recurrent periodontitis in high-risk patients.
    Aitken S; Birek P; Kulkarni GV; Lee WL; McCulloch CA
    J Periodontol; 1992 Feb; 63(2):87-92. PubMed ID: 1552469
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Preliminary evaluation of the use of methylene blue, a redox dye, in the treatment of chronic periodontitis.
    Gibson M; Wilson M; Strahan D; Harvey W
    Clin Infect Dis; 1993 Jun; 16 Suppl 4():S411-3. PubMed ID: 8324157
    [No Abstract]   [Full Text] [Related]  

  • 59. [Studies on efficacy, safety and dosage of rokitamycin in the treatment of pediatric infections].
    Hirosawa H; Ishikawa Y; Takahashi S; Matsuda H; Ichihashi H
    Jpn J Antibiot; 1988 Jun; 41(6):712-9. PubMed ID: 3221435
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of spiramycin and tetracycline used adjunctively in the treatment of advanced chronic periodontitis.
    Chin Quee T; Al-Joburi W; Lautar-Lemay C; Chan EC; Iugovaz I; Bourgouin J; Delorme F
    J Antimicrob Chemother; 1988 Jul; 22 Suppl B():171-7. PubMed ID: 3182440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.